Atrial fibrillation (AF), a leading cause of stroke, is an increasingly prevalent arrhythmia in the United States due to an aging population with predisposing conditions (e.g. heart failure, obesity, diabetes, high blood pressure, etc.). Although, there have been great technological advances in the treatment of AF, the current therapies still remain insufficient due to a limited understanding of the mechanisms that drive and maintain AF. Clinical studies currently lack reliable functional and structural mapping approaches necessary to resolve the detailed course of fast electrical activity during AF as a result of the highly complex patient-specific 3D structure of the human atria. Consequently, there remains a significant debate around the mechanism driving AF, the cause of these drivers, and how best to locate and treat these patient-specific drivers in patients with cardiac diseases. Therefore our study aims to develop a novel, paradigm-shifting framework that clearly identifies the exact electro-anatomical AF substrates, or AF driver ?fingerprints?, for optimal AF treatment in humans. Our preliminary data led us to hypothesize that a limited number of patient-specific sustained reentry circuits through fibrotically-insulated muscular bundles within the 3D atrial wall are responsible for the maintenance of AF. We will test this hypothesis, directly in explanted human atria, by integrating high resolution simultaneous endo-epicardial and panoramic optical mapping, clinical multi-electrode mapping, 3D structural gadolinium-enhanced MRI, and 3D heart-specific computational models to define the spatiotemporal and structural fingerprints of AF drivers in the human atria. Accurately defining the specific atrial functional-structural fingerprints of AF drivers will allow us to test the novel Substrate Modulating Ablation of Reentrant Tracks (SMART), a minimally damaging, personalized treatment of AF. This translational research is a critical step toward the development of new patient-specific therapies whereby AF drivers can be accurately defined, targeted, and successfully treated to cure the most common arrhythmia in the United States.

Public Health Relevance

Atrial fibrillation is an increasingly prevalent cardiac arrhythmia in the United States and a leading cause of stroke. Current treatments for atrial fibrillation are often ineffective and could have significant side effects. In this study, we will conduct a comprehensive and integrated study to unveil the mechanism of atrial fibrillation in order to develop new personalized therapies that successfully define, target, and treat the sources of atrial fibrillation in the human heart.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL135109-01A1
Application #
9384067
Study Section
Electrical Signaling, Ion Transport, and Arrhythmias Study Section (ESTA)
Program Officer
Shi, Yang
Project Start
2017-07-01
Project End
2021-03-31
Budget Start
2017-07-01
Budget End
2018-03-31
Support Year
1
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Ohio State University
Department
Physiology
Type
Schools of Medicine
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Bai, Jieyun; Gladding, Patrick A; Stiles, Martin K et al. (2018) Ionic and cellular mechanisms underlying TBX5/PITX2 insufficiency-induced atrial fibrillation: Insights from mathematical models of human atrial cells. Sci Rep 8:15642
Chung, Jae-Hoon; Martin, Brit L; Canan, Benjamin D et al. (2018) Etiology-dependent impairment of relaxation kinetics in right ventricular end-stage failing human myocardium. J Mol Cell Cardiol 121:81-93
Milani-Nejad, Nima; Chung, Jae-Hoon; Canan, Benjamin D et al. (2018) Increased cross-bridge recruitment contributes to transient increase in force generation beyond maximal capacity in human myocardium. J Mol Cell Cardiol 114:116-123
Hansen, Brian J; Zhao, Jichao; Li, Ning et al. (2018) Human Atrial Fibrillation Drivers Resolved With Integrated Functional and Structural Imaging to Benefit Clinical Mapping. JACC Clin Electrophysiol 4:1501-1515
Macri, Vincenzo; Brody, Jennifer A; Arking, Dan E et al. (2018) Common Coding Variants in SCN10A Are Associated With the Nav1.8 Late Current and Cardiac Conduction. Circ Genom Precis Med 11:e001663
Kalyanasundaram, Anuradha; Fedorov, Vadim V (2018) Lights on! Can visual light help distinguish fibrotic scars from ablation lesions? Heart Rhythm 15:576-577
Hansen, Brian J; Li, Ning; Helfrich, Katelynn M et al. (2018) First In Vivo Use of High-Resolution Near-Infrared Optical Mapping to Assess Atrial Activation During Sinus Rhythm and Atrial Fibrillation in a Large Animal Model. Circ Arrhythm Electrophysiol 11:e006870
Xiong, Zhaohan; Nash, Martyn P; Cheng, Elizabeth et al. (2018) ECG signal classification for the detection of cardiac arrhythmias using a convolutional recurrent neural network. Physiol Meas 39:094006
Li, Ning; Hansen, Brian J; Csepe, Thomas A et al. (2017) Redundant and diverse intranodal pacemakers and conduction pathways protect the human sinoatrial node from failure. Sci Transl Med 9:
Zhao, Jichao; Hansen, Brian J; Wang, Yufeng et al. (2017) Three-dimensional Integrated Functional, Structural, and Computational Mapping to Define the Structural ""Fingerprints"" of Heart-Specific Atrial Fibrillation Drivers in Human Heart Ex Vivo. J Am Heart Assoc 6:

Showing the most recent 10 out of 11 publications